Cargando…

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib

Prostate cancer is a leading cause of cancer death in men. Despite recent advances in our understanding and treatment of advanced disease, no systemic therapy is curative and new therapies are needed. Targeting angiogenesis is an attractive therapeutic strategy, as angiogenic pathways are upregulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltran, Himisha, Kaur, Gurveen, de España, Carmen Garcías, Tagawa, Scott T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104084/
https://www.ncbi.nlm.nih.gov/pubmed/24875818
http://dx.doi.org/10.4103/1008-682X.127822